Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewORYZON realizará múltiples actividades corporativas en conferencias internacionales en abr...
The biopharmaceutical company has been invited to participate or attend different events of reference within the biotechnology industry.
-
Press releaseBiotechnology lays the groundwork for the present and future of healthcare and drives the ...
AseBio's health pipeline includes 130 molecules for 150 indications being researched by 40 national companies, with oncology as the majority area. Spain stands out as one of the leading countries in
-
CompanyHIPRA HUMAN HEALTH S.L.U.
-
NewAseBio promotes the internationalization of Spanish biotech companies at major internation...
AseBio will participate as a member and coordinator, respectively, in different delegations representing Spain at two important events: the Anglo Nordic Life Sciences conference and Swiss Biotech Days
-
NewThe Spanish AI Healthcare Landscape
While not yet a global player, Artificial Intelligence (AI) is increasingly being integrated into the healthcare landscape in Spain, with the potential to significantly enhance patient care and
-
NewORYZON receives the INNOVATIVE SME seal from the Spanish Ministry of Science and Innovati...
La compañía biofarmacéutica ya ha sido inscrita en el Registro de Público de PYMES INNOVADORAS.
-
CompanyOWKIN
-
NewBarcelona Science Park awards prizes for 20th BATX2LAB programme
The Barcelona Science Park awarded the prizes for the 20th BATX2LAB, an initiative within the PCB RESSÒ programme that allows students in their first year of upper secondary school to carry out the
-
EventGenesis Conference
The annual Genesis conference bringkey Life Science opinion leaders and stakeholders together to debate key trends, instigate deals and generate a vision of the future.
-
EventBiopharm America
BioPharm America will merge with LSX World Congress USA this September, granting you access to a single larger, cohesive event.
-
EventChinaBIO Partnering Forum (virtual)
ChinaBio® Partnering Forum grants the global biopharma community the opportunity to broaden their reach into the China life science market through unmatched cross-border partnerships.
-
Event
ChinaBIO Partnering Forum
ChinaBio® Partnering Forum grants the global biopharma community the opportunity to broaden their reach into the China life science market through unmatched cross-border partnerships.
-
NewBiotechnology ranks third in patent applications in Spain in 2023
Applications in biotechnology have experienced a growth of 6.1% compared to the previous year, according to the latest report from the European Patent Office.
-
NewConsolidation of the BIOLANglobal digital platform as a benchmark for comprehensive and in...
BIOLAN is committed to continuously innovate and improve its platform to meet the changing needs that the market presents.
-
NewThe Role of Real-World Evidence in the Price and Reimbursement Decisions for Rare Diseases...
Real-world evidence (RWE) is a promising source of data that could help to accelerate drug access in rare diseases.
-
NewThe city of Vigo will host the next edition of "Galicia Biodays" on June 12 and 13
On June 12 and 13, Vigo will become the capital of biotechnology for the celebration of the II edition of "Galicia Biodays", the reference forum for the biotech and life sciences industry.
-
CompanyCMG MedDev S.L.
-
NewCeltarys Research, USC-biofarma and ZeClinics seek new therapeutic targets for Parkinson's...
This project, coordinated by Asebio, brings together ZeClinics' target validation and in vivo drug screening capabilities, Celtarys Research's scientific knowledge in fluorescent tool design and
-
NewAseBio welcomes the measures proposed by the European Commission to promote biotechnology ...
We consider it a priority to accelerate its implementation and broaden its scope of action to enhance and promote the development of biotechnology and bio-manufacturing, which are key to achieving
-
NewA consortium led by Hemostatics receives €2.5 M to validate a revolutionary therapy agains...
A public-private consortium, led by the Spanish biotech company Hemostatics, located in the Barcelona Science Park, and involving the Clínica Universidad de Navarra (CUN) and the Institute of Chemical
-
NewAlmirall signs licensing agreement with Eloxx Pharmaceuticals and enters the field of rare...
The Spanish pharmaceutical company has obtained global rights to develop and commercialize the drug ZKN-013.